MORELLI, MARTINA
MORELLI, MARTINA
DIPARTIMENTO DI MEDICINA
Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis
2022-01-01 Morelli, Martina; Galluzzo, Marco; Scarponi, Claudia; Madonna, Stefania; Luca Scaglione, Giovanni; Girolomoni, Giampiero; Talamonti, Marina; Bianchi, Luca; Albanesi, Cristina
HLA-Cw6 and other HLA-C alleles, as well as MICBDT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis
2021-01-01 Morelli, Martina; Galluzzo, Marco; Madonna, Stefania; Scarponi, Claudia; Luca Scaglione, Giovanni; Galluccio, Tiziana; Andreani, Marco; Pallotta, Sabatino; Girolomoni, Giampiero; Bianchi, Luca; Talamonti &, Marina; Albanesi, Cristina
Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21
2020-01-01 Mercurio, Laura; Lulli, Daniela; Mascia, Francesca; Dellambra, Elena; Scarponi, Claudia; Morelli, Martina; Valente, Carola; Carbone, Maria Luigia; Pallotta, Sabatino; Girolomoni, Giampiero; Albanesi, Cristina; Pastore, Saveria; Madonna, Stefania
Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development.
2020-01-01 Fania, L; Morelli, M; Scarponi, C; Mercurio, L; Scopelliti, F; Cattani, C; Scaglione, Gl; Tonanzi, T; Pilla, Ma; Pagnanelli, G; Mazzanti, C; Girolomoni, G; Cavani, A; Madonna, S; Albanesi, C.
PRECISION MEDICINE IN PSORIASIS: GENETIC INFLUENCE ON RESPONSIVENESS TO ANTI-ILs THERAPIES AND CLINICAL IMPLICATION OF PHARMACOLOGICAL TREATMENT WITH ANTI-TNF-alpha
2020-01-01 Morelli, Martina
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis | 1-gen-2022 | Morelli, Martina; Galluzzo, Marco; Scarponi, Claudia; Madonna, Stefania; Luca Scaglione, Giovanni; Girolomoni, Giampiero; Talamonti, Marina; Bianchi, Luca; Albanesi, Cristina | |
HLA-Cw6 and other HLA-C alleles, as well as MICBDT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis | 1-gen-2021 | Morelli, Martina; Galluzzo, Marco; Madonna, Stefania; Scarponi, Claudia; Luca Scaglione, Giovanni; Galluccio, Tiziana; Andreani, Marco; Pallotta, Sabatino; Girolomoni, Giampiero; Bianchi, Luca; Talamonti &, Marina; Albanesi, Cristina | |
Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21 | 1-gen-2020 | Mercurio, Laura; Lulli, Daniela; Mascia, Francesca; Dellambra, Elena; Scarponi, Claudia; Morelli, Martina; Valente, Carola; Carbone, Maria Luigia; Pallotta, Sabatino; Girolomoni, Giampiero; Albanesi, Cristina; Pastore, Saveria; Madonna, Stefania | |
Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development. | 1-gen-2020 | Fania, L; Morelli, M; Scarponi, C; Mercurio, L; Scopelliti, F; Cattani, C; Scaglione, Gl; Tonanzi, T; Pilla, Ma; Pagnanelli, G; Mazzanti, C; Girolomoni, G; Cavani, A; Madonna, S; Albanesi, C. | |
PRECISION MEDICINE IN PSORIASIS: GENETIC INFLUENCE ON RESPONSIVENESS TO ANTI-ILs THERAPIES AND CLINICAL IMPLICATION OF PHARMACOLOGICAL TREATMENT WITH ANTI-TNF-alpha | 1-gen-2020 | Morelli, Martina |